miRNAs involvement in the etiology and targeted therapy of bladder cancer: Interaction between signaling pathway
Abstract Bladder cancer (BC) accounts for roughly 3% of all cancer diagnoses in developed countries. The prognosis could be improved significantly if the cancer is detected and classified as either muscle‐invasive bladder cancer (MIBC) or non‐muscle‐invasive bladder cancer (NMIBC) as promptly as pos...
Main Authors: | Rishav Sharma, Rishabha Malviya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Precision Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1002/prm2.12119 |
Similar Items
-
A serum miRNAs signature for early diagnosis of bladder cancer
by: Zuhu Yu, et al.
Published: (2023-12-01) -
Urinary miRNAs as a Diagnostic Tool for Bladder Cancer: A Systematic Review
by: Anna Maria Grimaldi, et al.
Published: (2022-10-01) -
Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression
by: Cornelia Braicu, et al.
Published: (2019-10-01) -
The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer
by: Maria Iyali Torres-Bustamante, et al.
Published: (2024-02-01) -
Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine
by: Jen-Tai Lin, et al.
Published: (2021-04-01)